-
1
-
-
84871920581
-
Epidemiology and risk factors of urothelial bladder cancer
-
M. Burger, J.W. Catto, and G. Dalbagni et al. Epidemiology and risk factors of urothelial bladder cancer Eur Urol 63 2013 234 241
-
(2013)
Eur Urol
, vol.63
, pp. 234-241
-
-
Burger, M.1
Catto, J.W.2
Dalbagni, G.3
-
2
-
-
0003426141
-
-
Bethesda, MD: National Cancer Institute. Surveillance Epidemiology and End Results Web site
-
Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute. Surveillance Epidemiology and End Results Web site. http://seer.cancer.gov/csr/ 1975-2009-pops09.
-
SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations)
-
-
Howlader, N.1
Noone, A.M.2
Krapcho, M.3
-
3
-
-
33745609548
-
Adjuvant chemotherapy of bladder cancer
-
F. Boccardo, and L. Palmeri Adjuvant chemotherapy of bladder cancer Ann Oncol 17 Suppl 5 2006 v129 v132
-
(2006)
Ann Oncol
, vol.17
, Issue.SUPPL. 5
-
-
Boccardo, F.1
Palmeri, L.2
-
4
-
-
84870571565
-
ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings
-
C.N. Sternberg, J. Bellmunt, and G. Sonpavde et al. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings Eur Urol 63 2013 58 66
-
(2013)
Eur Urol
, vol.63
, pp. 58-66
-
-
Sternberg, C.N.1
Bellmunt, J.2
Sonpavde, G.3
-
5
-
-
21844450899
-
Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data: Advanced bladder cancer (ABC) meta-analysis collaboration
-
discussion 205-6
-
C.L. Vale Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 2005 202 206 discussion 205-6
-
(2005)
Eur Urol
, vol.48
, pp. 202-206
-
-
Vale, C.L.1
-
6
-
-
79961028436
-
Multi-institutional quality of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder [abstract 240]
-
A. Feifer, J.M. Taylor, and M. Shouery et al. Multi-institutional quality of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder [abstract 240] J Clin Oncol 29 Suppl 7 2011
-
(2011)
J Clin Oncol
, vol.29
, Issue.SUPPL. 7
-
-
Feifer, A.1
Taylor, J.M.2
Shouery, M.3
-
7
-
-
84859419726
-
Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: Results of a feasibility questionnaire
-
M. Burger, P. Mulders, and W. Witjes Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire Eur Urol 61 2012 1070 1071
-
(2012)
Eur Urol
, vol.61
, pp. 1070-1071
-
-
Burger, M.1
Mulders, P.2
Witjes, W.3
-
9
-
-
21844432174
-
Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
-
discussion 199-201
-
C.L. Vale Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 189 201 discussion 199-201
-
(2005)
Eur Urol
, vol.48
, pp. 189-201
-
-
Vale, C.L.1
-
10
-
-
33745056502
-
Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
-
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration
-
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Adjuvant chemotherapy for invasive bladder cancer (individual patient data) Cochrane Database Syst Rev 2006 CD006018
-
(2006)
Cochrane Database Syst Rev
, pp. 006018
-
-
-
11
-
-
84857509409
-
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: An Italian, multicenter, randomized phase III trial
-
F. Cognetti, E.M. Ruggeri, and A. Felici et al. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial Ann Oncol 23 2012 695 700
-
(2012)
Ann Oncol
, vol.23
, pp. 695-700
-
-
Cognetti, F.1
Ruggeri, E.M.2
Felici, A.3
-
13
-
-
79955969084
-
Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/ cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01study [abstract LBA4518]
-
L.G. Paz-Ares, E. Solsona, and E. Esteban et al. Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01study [abstract LBA4518] J Clin Oncol 28 2010 18
-
(2010)
J Clin Oncol
, vol.28
, pp. 18
-
-
Paz-Ares, L.G.1
Solsona, E.2
Esteban, E.3
-
14
-
-
80052737876
-
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status
-
W.M. Stadler, S.P. Lerner, and S. Groshen et al. Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status J Clin Oncol 29 2011 3443 3449
-
(2011)
J Clin Oncol
, vol.29
, pp. 3443-3449
-
-
Stadler, W.M.1
Lerner, S.P.2
Groshen, S.3
-
15
-
-
0028950013
-
Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long-term results of a controlled prospective study and further clinical experience
-
DOI 10.1097/00005392-199501000-00019
-
M. Stockle, W. Meyenburg, and S. Wellek et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience J Urol 153 1995 47 52 (Pubitemid 24379794)
-
(1995)
Journal of Urology
, vol.153
, Issue.1
, pp. 47-52
-
-
Stockle, M.1
Meyenburg, W.2
Wellek, S.3
Voges, G.E.4
Rossmann, M.5
Gertenbach, U.6
Thuroff, J.W.7
Huber, C.8
Hohenfellner, R.9
-
16
-
-
33644797618
-
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
-
J. Lehmann, L. Franzaring, J. Thuroff, S. Wellek, and M. Stockle Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer BJU Int 97 2006 42 47
-
(2006)
BJU Int
, vol.97
, pp. 42-47
-
-
Lehmann, J.1
Franzaring, L.2
Thuroff, J.3
Wellek, S.4
Stockle, M.5
-
18
-
-
0032583387
-
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
-
DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0. CO;2-8
-
M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834 (Pubitemid 28562978)
-
(1998)
Statistics in Medicine
, vol.17
, Issue.24
, pp. 2815-2834
-
-
Parmar, M.K.B.1
Torri, V.2
Stewart, L.3
-
20
-
-
33845571913
-
Random-effects model for meta-analysis of clinical trials: An update
-
DOI 10.1016/j.cct.2006.04.004, PII S1551714406000486
-
R. DerSimonian, and R. Kacker Random-effects model for meta-analysis of clinical trials: an update Contemp Clin Trials 28 2007 105 114 (Pubitemid 44937874)
-
(2007)
Contemporary Clinical Trials
, vol.28
, Issue.2
, pp. 105-114
-
-
DerSimonian, R.1
Kacker, R.2
-
21
-
-
0041876133
-
Measuring inconsistency in meta-analyses
-
J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
-
(2003)
British Medical Journal
, vol.327
, Issue.7414
, pp. 557-560
-
-
Higgins, J.P.T.1
Thompson, S.G.2
Deeks, J.J.3
Altman, D.G.4
-
22
-
-
0037186429
-
Advanced methods in meta-analysis: Multivariate approach and meta-regression
-
DOI 10.1002/sim.1040
-
H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: multivariate approach and meta-regression Stat Med 21 2002 589 624 (Pubitemid 34141379)
-
(2002)
Statistics in Medicine
, vol.21
, Issue.4
, pp. 589-624
-
-
Van Houwelingen, H.C.1
Arends, L.R.2
Stijnen, T.3
-
23
-
-
84859001212
-
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
-
J.P. Higgins, D.G. Altman, and P.C. Gotzsche et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928
-
(2011)
BMJ
, vol.343
, pp. 5928
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
-
24
-
-
68549101842
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
-
A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
-
(2009)
BMJ
, vol.339
, pp. 2700
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
-
25
-
-
0030938439
-
Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study
-
A.V. Bono, C. Benvenuti, and A. Gibba et al. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study Acta Urol Ital 11 1997 5 8 (Pubitemid 27189531)
-
(1997)
Acta Urologica Italica
, vol.11
, Issue.1
, pp. 5-8
-
-
Bono, A.V.1
Benvenuti, C.2
Gibba, A.3
Guazzeri, S.4
Cosciani-Cunico, S.5
Anselmo, G.6
Martini, E.7
Parma, G.8
Ferrari, P.9
Viggiano, G.10
-
26
-
-
0030049159
-
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer
-
discussion 499-500
-
F. Freiha, J. Reese, and F.M. Torti A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer J Urol 155 1996 495 499 discussion 499-500
-
(1996)
J Urol
, vol.155
, pp. 495-499
-
-
Freiha, F.1
Reese, J.2
Torti, F.M.3
-
27
-
-
0242405666
-
Perioperative chemotherapy in advanced bladder cancer - Part II: Adjuvant treatment
-
DOI 10.1159/000072983
-
T. Otto, P.J. Goebell, and H. Rubben Perioperative chemotherapy in advanced bladder cancer - Part II: adjuvant treatment Onkologie 26 2003 484 488 (Pubitemid 37409895)
-
(2003)
Onkologie
, vol.26
, Issue.5
, pp. 484-488
-
-
Otto, T.1
Goebell, P.J.2
Rubben, H.3
-
28
-
-
0025822201
-
The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial
-
discussion 464-7
-
D.G. Skinner, J.R. Daniels, and C.A. Russell et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urol 145 1991 459 464 discussion 464-7
-
(1991)
J Urol
, vol.145
, pp. 459-464
-
-
Skinner, D.G.1
Daniels, J.R.2
Russell, C.A.3
-
29
-
-
0028291549
-
Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial
-
U.E. Studer, M. Bacchi, and C. Biedermann et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial J Urol 152 1994 81 84 (Pubitemid 24175706)
-
(1994)
Journal of Urology
, vol.152
, Issue.1
, pp. 81-84
-
-
Studer, U.E.1
Bacchi, M.2
Biedermann, C.3
Jaeger, P.4
Kraft, R.5
Mazzucchelli, L.6
Markwalder, R.7
Senn, E.8
Sonntag, R.W.9
-
30
-
-
81255204165
-
Intention-to-treat concept: A review
-
S.K. Gupta Intention-to-treat concept: a review Perspect Clin Res 2 2011 109 112
-
(2011)
Perspect Clin Res
, vol.2
, pp. 109-112
-
-
Gupta, S.K.1
-
32
-
-
84899483711
-
-
National Cancer Institute ClinicalTrials.gov Web site
-
National Cancer Institute. Ad/HER2/neu dendritic cell cancer vaccine testing. ClinicalTrials.gov Web site. www.clinicaltrials.gov/show/NCT1730118.
-
Ad/HER2/neu Dendritic Cell Cancer Vaccine Testing
-
-
-
33
-
-
84864423349
-
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer
-
J.J. Meeks, J. Bellmunt, and B.H. Bochner et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 62 2012 523 533
-
(2012)
Eur Urol
, vol.62
, pp. 523-533
-
-
Meeks, J.J.1
Bellmunt, J.2
Bochner, B.H.3
-
34
-
-
0037866815
-
Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis
-
Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 2003 1927 1934
-
(2003)
Lancet
, vol.361
, pp. 1927-1934
-
-
-
35
-
-
34548144894
-
Neoadjuvant chemotherapy for invasive bladder cancer
-
Neoadjuvant chemotherapy for invasive bladder cancer Cochrane Database Syst Rev 2005 CD005246
-
(2005)
Cochrane Database Syst Rev
, pp. 005246
-
-
-
36
-
-
79955731409
-
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer
-
M.P. Porter, M.C. Kerrigan, B.M. Donato, and S.D. Ramsey Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer Urol Oncol 29 2011 252 258
-
(2011)
Urol Oncol
, vol.29
, pp. 252-258
-
-
Porter, M.P.1
Kerrigan, M.C.2
Donato, B.M.3
Ramsey, S.D.4
-
37
-
-
34447095141
-
Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base
-
DOI 10.1016/j.juro.2007.03.101, PII S0022534707007495
-
K.A. David, M.I. Milowsky, J. Ritchey, P.R. Carroll, and D.M. Nanus Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base J Urol 178 2007 451 454 (Pubitemid 47030482)
-
(2007)
Journal of Urology
, vol.178
, Issue.2
, pp. 451-454
-
-
David, K.A.1
Milowsky, M.I.2
Ritchey, J.3
Carroll, P.R.4
Nanus, D.M.5
-
38
-
-
56249148146
-
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: A high-volume tertiary cancer center experience
-
S.M. Donat, A. Shabsigh, and C. Savage et al. Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience Eur Urol 55 2009 177 186
-
(2009)
Eur Urol
, vol.55
, pp. 177-186
-
-
Donat, S.M.1
Shabsigh, A.2
Savage, C.3
-
39
-
-
0021417031
-
Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities
-
A.B. Einstein Jr., W. Shipley, J. Coombs, K.B. Cummings, M.S. Soloway, and I. Hawkins Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities Urology 23 1984 110 117
-
(1984)
Urology
, vol.23
, pp. 110-117
-
-
Einstein Jr., A.B.1
Shipley, W.2
Coombs, J.3
Cummings, K.B.4
Soloway, M.S.5
Hawkins, I.6
-
40
-
-
0020540673
-
Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy
-
B. Richards, J.R. Bastable, and L. Freedman et al. Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy Brit J Urol 55 1983 386 391 (Pubitemid 13076311)
-
(1983)
British Journal of Urology
, vol.55
, Issue.4
, pp. 386-391
-
-
Richards, B.1
Bastable, J.R.G.2
Freedman, L.3
-
41
-
-
0024209884
-
Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: Preliminary report
-
R.J. Shearer, C.F. Chilvers, H.J. Bloom, J.M. Bliss, A. Horwich, and A. Babiker Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report Brit J Urol 62 1988 558 564 (Pubitemid 19002675)
-
(1988)
British Journal of Urology
, vol.62
, Issue.6
, pp. 558-564
-
-
Shearer, R.J.1
Chilvers, C.E.D.2
Bloom, H.J.G.3
Bliss, J.M.4
Horwich, A.5
Babiker, A.6
-
42
-
-
84863897662
-
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987
-
J. Bellmunt, H. von der Maase, and G.M. Mead et al. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987 J. Clin. Oncol 30 2012 1107 1113
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 1107-1113
-
-
Bellmunt, J.1
Von Der Maase, H.2
Mead, G.M.3
|